Toplam 2 sonuçtan 1 ile 2 arasındakiler gösteriliyor.

Konu: 2010 mart üds sağlık

  1. #1
    Üyelik tarihi
    Jun 2009
    Yaş
    30
    Mesajlar
    130
    Teşekkür / Beğenme
    Rep Gücü
    16

    2010 mart üds sağlık

    A new vaccine that may offer lifetime protection against the flu has shown promise in human trials. It works on the deadly type A strain, responsible for pandemics. Current flu vaccines work by giving immunity against two proteins, called haemagglutinin and neurominidase, found on the surface of flu viruses. However, as these proteins continually mutate, vaccines have to be reformulated every year to keep on working. The new vaccine, known as
    ACAM-FLU-A, gets around this problem by homing in on a protein called M2, found on all type A strains, that does not mutate so readily. The vaccine could be quickly produced in response to a flu outbreak. The doses can be mass produced and used at any time, because there is no need to identify the most prevalent strains. In theory, a single injection could
    offer lifetime protection. Whether this will work in practice is a matter for future trials.

    60. One can understand from the passage that flu vaccines currently on the market ----.
    A) do not provide lifetime immunity to the type A strain of flu
    B) have proven rather promising in human trials
    C) eliminate the need to identify the most prevalent strains of flu
    D) give immunity against the M2 protein
    E) are subject to future trials on other strains

  2. #2
    Üyelik tarihi
    Aug 2008
    Yaş
    40
    Mesajlar
    11,396
    Teşekkür / Beğenme
    Rep Gücü
    139
    Alıntı eda1987 isimli üyeden alıntı Mesajı göster
    A new vaccine that may offer lifetime protection against the flu has shown promise in human trials. It works on the deadly type A strain, responsible for pandemics. Current flu vaccines work by giving immunity against two proteins, called haemagglutinin and neurominidase, found on the surface of flu viruses. However, as these proteins continually mutate, vaccines have to be reformulated every year to keep on working. The new vaccine, known as
    ACAM-FLU-A, gets around this problem
    by homing in on a protein called M2, found on all type A strains, that does not mutate so readily. The vaccine could be quickly produced in response to a flu outbreak. The doses can be mass produced and used at any time, because there is no need to identify the most prevalent strains. In theory, a single injection could
    offer lifetime protection.
    Whether this will work in practice is a matter for future trials.

    60. One can understand from the passage that flu vaccines currently on the market ----.
    A)do not provide lifetime immunity to the type A strain of flu)
    B) have proven rather promising in human trials
    C) eliminate the need to identify the most prevalent strains of flu
    D) give immunity against the M2 protein
    E) are subject to future trials on other strains
    ........................


Konu Bilgisi

Users Browsing this Thread

Şu anda 1 üyemiz bu konuya göz atıyor. (0 kayıtlı üye ve 1 misafir.)

Benzer Konular

  1. 2010 mart sağlık üds
    Konuyu Açan: eda1987, Forum: ÜDS Diyalog Tamamlama Soruları.
    Cevaplar: 1
    Son Mesaj : 28-08-12, 21:34
  2. 2010 mart üds sağlık
    Konuyu Açan: eda1987, Forum: ÜDS Akışı Bozan Cümle Soruları.
    Cevaplar: 6
    Son Mesaj : 25-02-11, 18:14
  3. 2010 mart üds sağlık
    Konuyu Açan: eda1987, Forum: ÜDS Akışı Bozan Cümle Soruları.
    Cevaplar: 0
    Son Mesaj : 24-02-11, 17:22
  4. 2010 Mart ÜDS Sağlık Bilimleri [Soru ve Cevaplar]
    Konuyu Açan: SeyfiHoca, Forum: ÜDS Forumu.
    Cevaplar: 169
    Son Mesaj : 29-03-10, 01:01
  5. 2006 mart üds -sağlık
    Konuyu Açan: TWETY, Forum: ÜDS Forumu.
    Cevaplar: 1
    Son Mesaj : 18-03-10, 00:55

Bu Konu İçin Etiketler

Bu Konuyu Paylaşın !

Yetkileriniz

  • Konu Acma Yetkiniz Yok
  • Cevap Yazma Yetkiniz Yok
  • Eklenti Yükleme Yetkiniz Yok
  • Mesajınızı Değiştirme Yetkiniz Yok
  •